Kymera Therapeutics KYMR Q1 2025 earnings
Reported May 9, 2025 · Before market open
Revenue$22.1MBeat by $9.7M
EPS-$0.82Beat by $0.10
Revenue estimate$12.4M
EPS estimate-$0.92
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$32.2M
EPS estimate-$0.72
Financials
Q1 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Kymera Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Kymera Therapeutics report Q1 2025 earnings?
- Kymera Therapeutics (KYMR) reported Q1 2025 earnings on May 9, 2025 before market open.
- What were Kymera Therapeutics's Q1 2025 revenue and EPS?
- Kymera Therapeutics reported revenue of $22.1M and eps of $-0.82 for Q1 2025.
- Did Kymera Therapeutics beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $12.4M by $9.7M. EPS beat the consensus estimate of $-0.92 by $0.10.
- How did Kymera Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 114.8% from $10.3M a year earlier and eps declined 18.8% from $-0.69.
- Where can I find Kymera Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-067498) directly on SEC EDGAR. The filing index links above go to sec.gov.